Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiotech Gwth Regulatory News (BIOG)

Share Price Information for Biotech Gwth (BIOG)

Share Price is delayed by 15 minutes
Get Live Data
1,448.00    44.00 (3.13%)
Bid:
1,436.00
Ask:
1,454.00
Spread: 18.00 (1.253%)
Market Cap: £278.85m
BIOG Live PriceLast checked at - London Stock Exchange

Intraday Biotech Gwth Share Chart

Total Voting Rights

2 Jan 2024 09:32

The Biotech Growth Trust Plc - Total Voting Rights

The Biotech Growth Trust Plc - Total Voting Rights

PR Newswire

LONDON, United Kingdom, January 02

The Biotech Growth Trust PLC

2 January 2024

The Biotech Growth Trust PLC

Voting Rights and Capital

In accordance with the Financial Conduct Authority's Disclosure Guidance and Transparency Rules, The Biotech Growth Trust PLC (the "Company") announces the following:

As at 31 December 2023, the Company capital consists of ordinary shares of 25p with each ordinary share holding one voting right. The total number of ordinary shares in issue is 34,555,600. The Company has no ordinary shares in Treasury.

Therefore, the total number of voting rights in the Company is 34,555,600.

The above figure (34,555,600) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in the Company or a change to their interest in the Company, under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

- END -

Frostrow Capital LLP

Company Secretary

Tel: 0203 709 8734



Date   Source Headline
16th Jan 20265:08 pmPRNTransaction in Own Shares
16th Jan 20262:20 pmPRNNet Asset Value(s)
15th Jan 20262:39 pmPRNNet Asset Value(s)
15th Jan 20262:32 pmPRNMonthly Fact Sheet as at 31 December 2025
14th Jan 20261:18 pmPRNNet Asset Value(s)
13th Jan 202612:33 pmPRNNet Asset Value(s)
12th Jan 20261:10 pmPRNNet Asset Value(s)
9th Jan 20265:20 pmPRNTransaction in Own Shares
9th Jan 20262:15 pmPRNNet Asset Value(s)
8th Jan 20261:01 pmPRNNet Asset Value(s)
7th Jan 20261:14 pmPRNNet Asset Value(s)
6th Jan 20261:12 pmPRNNet Asset Value(s)
5th Jan 20261:06 pmPRNNet Asset Value(s)
2nd Jan 20261:48 pmPRNNet Asset Value(s)
2nd Jan 202610:37 amPRNTotal Voting Rights
31st Dec 202512:13 pmPRNNet Asset Value(s)
30th Dec 20255:18 pmRNSTransaction in Own Shares
30th Dec 20255:18 pmPRNTransaction in Own Shares
30th Dec 20251:33 pmPRNNet Asset Value(s)
29th Dec 20251:56 pmPRNNet Asset Value(s)
24th Dec 202511:38 amPRNNet Asset Value(s)
23rd Dec 20255:13 pmRNSTransaction in Own Shares
23rd Dec 20255:13 pmPRNTransaction in Own Shares
23rd Dec 202512:07 pmPRNNet Asset Value(s)
22nd Dec 202512:55 pmRNSBioMarin Pharmaceuticals to acquire BIOG portfolio company, Amicus Therapeutics
22nd Dec 202512:55 pmPRNBioMarin Pharmaceuticals to acquire BIOG portfolio company, Amicus Therapeutics
22nd Dec 202512:26 pmPRNNet Asset Value(s)
19th Dec 20255:27 pmRNSTransaction in Own Shares
19th Dec 20255:27 pmPRNTransaction in Own Shares
19th Dec 20251:46 pmPRNNet Asset Value(s)
18th Dec 20254:00 pmPRNNet Asset Value(s)
17th Dec 20252:00 pmPRNNet Asset Value(s)
16th Dec 202512:41 pmPRNNet Asset Value(s)
15th Dec 20251:59 pmPRNNet Asset Value(s)
12th Dec 20255:33 pmPRNTransaction in Own Shares
12th Dec 20252:24 pmPRNMonthly Fact Sheet as at 30 November 2025
12th Dec 20252:20 pmPRNNet Asset Value(s)
11th Dec 20251:58 pmPRNNet Asset Value(s)
10th Dec 202512:56 pmPRNNet Asset Value(s)
9th Dec 20251:21 pmPRNNet Asset Value(s)
8th Dec 20251:24 pmPRNNet Asset Value(s)
5th Dec 20255:18 pmPRNTransaction in Own Shares
5th Dec 20252:24 pmPRNNet Asset Value(s)
4th Dec 20251:28 pmPRNNet Asset Value(s)
3rd Dec 20253:46 pmPRNNet Asset Value(s)
2nd Dec 20253:31 pmPRNDirector Declaration
2nd Dec 20251:24 pmPRNNet Asset Value(s)
1st Dec 20252:36 pmPRNNet Asset Value(s)
1st Dec 20259:47 amPRNTotal Voting Rights
28th Nov 20255:17 pmPRNTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.